Johns Hopkins University

Johns Hopkins Launches $10M Fed-Funded Study Of 10,000 Medical Marijuana Patients: What We Can Expect
Three Johns Hopkins Psychedelics Professors Call The Shots On Live Q&A: Knowns, Unknowns, Regulations & Hopes
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
Three Johns Hopkins Psychedelics Professors Call The Shots On Live Q&A: Knowns, Unknowns, Regulations & Hopes
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
'Right Around The Corner' — Economist Steve Hanke Predicts Recession, Deems Stocks 'Pretty Pricey'
Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More

Johns Hopkins University Recent News

Johns Hopkins Professor Steve Hanke Says Price Cap On Russian Oil Will Further 'Politicize' Market: 'Customers Will Pay The Bill'
Steve Hanke, Professor of Applied Economics at Johns Hopkins University, has reiterated his skepticism about the impact of Western sanctions on the oil market stating that it would be the customers
Lower Risk Of Lung Injury From Contaminated Vapes Less Frequent In Legal Cannabis States, Study Finds
A new study analyzed the prevalence of cannabis vaping, cases of e-cigarette or vaping product-use-associated lung injury (EVALI), and marijuana laws in 13 states.
Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved
Biotech company Mydecine Innovations Group (OTC: MYCOF) received FDA approval for their novel proprietary MYCO-001. This is the first clearance of the company’s drug product. 
Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study
Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. A new Johns Hopkins review study found that the positive effects of just two sessions of psilocybin-assisted psychotherapy can last for over one year in most patients with depression.
Johns Hopkins: New Study Backs Claims That Cannabis Can Reduce Anxiety And Depression
Cannabis is becoming universally known as a mood enhancer and anxiety-reducing substance.  However, the plant notoriously lacks clinical research to inform its safe and correct use in specific psychiatric disorders like anxiety and depression.
Michigan State Senators Introduce Bill To Decriminalize Psychedelics, Call For More Research
Michigan Senators Jeff Irwin (D-Ann Arbor) and Adam Hollier (D-Detroit) co-sponsored and introduced legislation last week that would decriminalize the use of psilocybin and mescaline and allow the possession, cultivation and delivery of these two types of psychedelics.
PharmaDrug Strikes Deal With Johns Hopkins University For A Clinical Trial Into Psychedelic DMT
On Wednesday, PharmaDrug Inc. (CSE: PHRX) (OTCPINK: LMLLF), a company researching DMT and other psychedelics for medical purposes, announced a new clinical trial agreement with Johns Hopkins University, one of the leading research institutions in the space.
Mydecine Innovations Inks Deal With Johns Hopkins University To Undertake Psychedelics Research Into Smoking Cessation
Mydecine Innovations Group (NEO: MYCO) (OTCPINK: MYCOF) has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, to study the application of psychedelics molecules and therapies in smoking cessation.
El Salvador's Decision On Bitcoin Is 'Nonsensical' And Could 'Collapse The Economy,' Economist Says
Steve Hanke — the professor of applied economics at Johns Hopkins University who served as a senior economist under President Ronald Reagan from 1981 to 1982 — said that Bitcoin (CRYPTO: BTC) adoption could "completely collapse the economy" of El Salvador.
Abbott Announces HIV Vaccine Research Findings: 'Another Step Toward Unlocking A Cure'
Abbott Laboratories (NYSE: ABT) has announced a potential research breakthrough that could lead to advancements and potential vaccines for the treatment of HIV.
Johns Hopkins University To Research Cannabinoid Therapies Via New Partnership
Johns Hopkins University is collaborating with Realm of Caring and Bloom Medical on a research initiative focused on cannabinoid therapies. The research will center on the collection of “substantive, educational data” currently available in legal medical cannabis markets.
COVID-19 Vaccine Updates: J&J Identifies Lead Candidate, IMV Eyes Clinical Testing In Summer, Altimmune Partners With University Of Alabama
Coronavirus Pandemic Has College-Bound Students, Parents Rethinking Higher Education Decisions
'Spider-Man' Glenn King Hopes His Potential Stroke-Saving Arachnid Molecule Makes It To Market
Slingshot Insights' Expert Conference Call On Lipocine
Michael Bloomberg And Joe Biden Lay Out How We Can Beat Cancer
These 24 Charitable Donations Are the Most Generous of 2013 (So Far)